Editas Medicine (EDIT) Assets (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Assets data on file, last reported at $186.5 million in Q4 2025.

• Quarterly Assets fell 45.39% year-over-year to $186.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $186.5 million (down 45.39% YoY) and the FY2025 annual result came in at $186.5 million, down 45.39% from the prior year.
• Assets declined to $186.5 million in Q4 2025 per EDIT's latest filing, from $201.8 million in the prior quarter.
• Across five years, Assets topped out at $780.3 million in Q1 2021 and bottomed at $186.5 million in Q4 2025.
• The 5-year median for Assets is $501.9 million (2023), against an average of $477.3 million.
• The widest annual swing landed in 2021, when Assets soared 67.18%; it then sank 45.39% in 2025.
• Tracing EDIT's Assets over 5 years: stood at $677.5 million in 2021, then dropped by 24.08% to $514.3 million in 2022, then decreased by 2.95% to $499.2 million in 2023, then slumped by 31.57% to $341.6 million in 2024, then slumped by 45.39% to $186.5 million in 2025.
• Per Business Quant, the three latest EDIT Assets figures stand at $186.5 million (Q4 2025), $201.8 million (Q3 2025), and $210.6 million (Q2 2025).

Peer Comparison